MED-EL Corporation Company Profile

22:19 EDT 22nd September 2014 | BioPortfolio

Since its founders developed one of the world’s first cochlear implants in the 1970s, MED-EL has set new standards in hearing implant technologies, developing and manufacturing technologically advanced hearing solutions for people with varying degrees of hearing loss. MED-EL hearing implant systems, currently used in 96 countries, combine the latest scientific advances, engineering and manufacturing techniques for performance, safety and reliability. MED-EL offers the broadest portfolio of hearing implant systems, including the MAESTRO Cochlear Implant system for those with severe-to-profound sensorineural hearing loss and the unique Vibrant Soundbridge®, a middle ear prosthesis for the treatment of moderate to severe sensorineural hearing loss. The fast-growing medical technology company employs more than 1,000 people worldwide, more than 650 of whom are based at the company’s headquarters in Innsbruck, where R&D and production are located. For more information, visit www.medel.com or call 888-MED-EL-CI (633-3524).


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [0 Results]

None

More Information about "MED-EL Corporation" on BioPortfolio

We have published hundreds of MED-EL Corporation news stories on BioPortfolio along with dozens of MED-EL Corporation Clinical Trials and PubMed Articles about MED-EL Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MED-EL Corporation Companies in our database. You can also find out about relevant MED-EL Corporation Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record